OBSOLETE: Thoracolumbosacral spina bifida cystica

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:268752
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Thoracolumbosacral spina bifida cystica is a neural tube defect in which the spinal column fails to close properly during embryonic development, affecting the thoracic, lumbar, and sacral regions of the spine. This entry is now classified as OBSOLETE in the Orphanet database, meaning it has been retired and its clinical content has been reorganized under broader or more specific spina bifida classifications. Spina bifida cystica refers to forms of spina bifida where a cyst-like sac protrudes through the defect in the spine, which may contain meninges alone (meningocele) or meninges along with spinal cord tissue (myelomeningocele). The thoracolumbosacral designation indicates that the defect spans a large segment of the spine, from the thoracic through the sacral region. Patients with this extensive form of spina bifida cystica typically present at birth with a visible sac on the back, and the condition can cause significant neurological impairment including lower limb paralysis or weakness, loss of sensation below the level of the defect, and bowel and bladder dysfunction. Hydrocephalus is a common associated finding, often requiring cerebrospinal fluid shunting. Orthopedic complications such as clubfoot, hip dislocation, and scoliosis may also occur. The extent of neurological deficit generally correlates with the level and severity of the spinal defect, and involvement of the thoracic region typically results in more severe disability compared to lower-level defects. Management is multidisciplinary and begins with surgical closure of the defect, ideally within the first days of life, or in some cases prenatally through fetal surgery. Ongoing care involves neurosurgery, urology, orthopedics, physical therapy, and rehabilitation services. Folic acid supplementation before and during early pregnancy has been shown to significantly reduce the risk of neural tube defects. While there is no cure, advances in surgical techniques and supportive care have improved outcomes and quality of life for affected individuals.

Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Thoracolumbosacral spina bifida cystica.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Thoracolumbosacral spina bifida cystica at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Thoracolumbosacral spina bifida cystica community →

No specialists are currently listed for OBSOLETE: Thoracolumbosacral spina bifida cystica.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Thoracolumbosacral spina bifida cystica.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Thoracolumbosacral spina bifida cysticaForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Thoracolumbosacral spina bifida cystica.

Start the conversation →

Latest news about OBSOLETE: Thoracolumbosacral spina bifida cystica

No recent news articles for OBSOLETE: Thoracolumbosacral spina bifida cystica.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about OBSOLETE: Thoracolumbosacral spina bifida cystica

What is OBSOLETE: Thoracolumbosacral spina bifida cystica?

Thoracolumbosacral spina bifida cystica is a neural tube defect in which the spinal column fails to close properly during embryonic development, affecting the thoracic, lumbar, and sacral regions of the spine. This entry is now classified as OBSOLETE in the Orphanet database, meaning it has been retired and its clinical content has been reorganized under broader or more specific spina bifida classifications. Spina bifida cystica refers to forms of spina bifida where a cyst-like sac protrudes through the defect in the spine, which may contain meninges alone (meningocele) or meninges along with

How is OBSOLETE: Thoracolumbosacral spina bifida cystica inherited?

OBSOLETE: Thoracolumbosacral spina bifida cystica follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does OBSOLETE: Thoracolumbosacral spina bifida cystica typically begin?

Typical onset of OBSOLETE: Thoracolumbosacral spina bifida cystica is neonatal. Age of onset can vary across affected individuals.